Cancel
Jeff Bluestone
Chief Executive Officer and President
@
Sonoma BioTherapeutics
z11qz0hp5@6tq57uh3p.70v
Sign up to see email
Known information
- Elected to the National Academy of Sciences
- Former President and CEO of the Parker Institute for Cancer Immunotherapy
- Was the founding director of the Immune Tolerance Network
- Holds the A.W. and Mary Margaret Clausen Distinguished Professorship in Metabolism and Endocrinology at UCSF
- Former executive vice chancellor and provost emeritus at UCSF
- Former director of the UCSF Diabetes Center
- Received a Guggenheim Fellowship
- Member of Vice President Joe Biden’s Cancer Moonshot Blue Ribbon Panel
- Elected to the American Academy of Arts and Sciences
- Elected to the National Academy of Medicine
About Sonoma BioTherapeutics
Sonoma BioTherapeutics is a clinical-stage biotechnology company focused on developing engineered regulatory T cell therapies for autoimmune and inflammatory diseases, with proprietary technologies and a new manufacturing facility in Seattle.
Report inaccurate information
